Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Wilcox

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1995
Measurement of Ca2+ fluxes in permeabilized cells using 45Ca2+ and fluo-3R A Wilcox, J Strupish, S R Nahorski
Methods in Molecular Biology (Clifton, N.J.)|March 19, 1999
Microinjection of myo-inositol(1,4,5)trisphosphate and other calcium-mobilizing agents into intact adherent cellsR A Wilcox, I D Forsythe, T J McCann
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 4, 2008
Hashimoto's encephalopathy masquerading as acute psychosisR A Wilcox, T To, A Koukourou, et al.
European Journal of Pharmacology|May 27, 1986
Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivoR A Wilcox, T E Robinson, J B Becker
Clinical Excellence for Nurse Practitioners : the International Journal of NPACE|July 18, 2001
Perceived barriers to rural nurse practitioner practiceL L Lindeke, T R Bly, R A Wilcox
FEBS Letters|February 3, 1997
Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, A Fauq, A P Kozikowski, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1994
Phosphoinositide-derived second messengers and the regulation of Ca2+ in vascular smooth muscleS R Nahorski, R A Wilcox, J J Mackrill, et al.
Trends in Pharmacological Sciences|December 16, 1998
New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, W U Primrose, S R Nahorski, et al.
Biochemical Society Transactions|August 1, 1995
2-Hydroxyethyl alpha-D-glucopyranoside 2,3',4'-trisphosphate: a novel metabolically resistant adenophostin A and myo-inositol 1,4,5-trisphosphate analogue potently interacts with the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, C Erneux, W U Primrose, et al.
Molecular Pharmacology|June 1, 1995
2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptorR A Wilcox, C Erneux, W U Primrose, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1995
Measurement of Ca2+ fluxes in permeabilized cells using 45Ca2+ and fluo-3R A Wilcox, J Strupish, S R Nahorski
Methods in Molecular Biology (Clifton, N.J.)|March 19, 1999
Microinjection of myo-inositol(1,4,5)trisphosphate and other calcium-mobilizing agents into intact adherent cellsR A Wilcox, I D Forsythe, T J McCann
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 4, 2008
Hashimoto's encephalopathy masquerading as acute psychosisR A Wilcox, T To, A Koukourou, et al.
European Journal of Pharmacology|May 27, 1986
Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivoR A Wilcox, T E Robinson, J B Becker
Clinical Excellence for Nurse Practitioners : the International Journal of NPACE|July 18, 2001
Perceived barriers to rural nurse practitioner practiceL L Lindeke, T R Bly, R A Wilcox
FEBS Letters|February 3, 1997
Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, A Fauq, A P Kozikowski, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1994
Phosphoinositide-derived second messengers and the regulation of Ca2+ in vascular smooth muscleS R Nahorski, R A Wilcox, J J Mackrill, et al.
Trends in Pharmacological Sciences|December 16, 1998
New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, W U Primrose, S R Nahorski, et al.
Biochemical Society Transactions|August 1, 1995
2-Hydroxyethyl alpha-D-glucopyranoside 2,3',4'-trisphosphate: a novel metabolically resistant adenophostin A and myo-inositol 1,4,5-trisphosphate analogue potently interacts with the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, C Erneux, W U Primrose, et al.
Molecular Pharmacology|June 1, 1995
2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptorR A Wilcox, C Erneux, W U Primrose, et al.
Pageof 4